Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wyde, M. E.
Right arrow Articles by Walker, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wyde, M. E.
Right arrow Articles by Walker, N. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 54, 493-499 (2000)
Copyright © 2000 by the Society of Toxicology

Toxicity of Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Diethylnitrosamine-Initiated Ovariectomized Rats Implanted with Subcutaneous 17 ß-Estradiol Pellets

Michael E. Wyde*,{dagger}, John Seely{ddagger}, George W. Lucier{dagger} and Nigel J. Walker{dagger},1

* Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina; {dagger} National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; and {ddagger} Pathco Inc., Research Triangle Park, North Carolina

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a potent hepatocarcinogen in female but not in male rats. Several lines of evidence suggest a key role of ovarian hormones, presumably estrogen, in the mechanism of TCDD-induced hepatocarcinogenesis. The aim of this current study was to determine the toxicity of co-treatment with TCDD and 17 ß-estradiol and assess the efficacy of 90-day subcutaneous constant release 17 ß-estradiol pellets. Ovariectomized (OVX) female Sprague-Dawley rats were initiated with diethylnitrosamine (DEN) and treated with TCDD for 20 or 30 weeks in the presence and absence of 17 ß-estradiol. TCDD concentrations were equivalent in livers of TCDD-treated sham operated and OVX rats following 20 weeks of treatment. Following 30 weeks of TCDD treatment, liver TCDD concentrations were higher in OVX rats than in intact rats. TCDD concentrations in livers of TCDD-treated OVX rats receiving supplemental 17 ß-estradiol were similar to intact rats following either 20 or 30 weeks of treatment. Mean hepatic background TCDD concentrations in untreated rats were 2-fold higher in intact rats compared to OVX rats, regardless of 17 ß-estradiol exposure following 20, but not 30 weeks of treatment. Serum indicators of hepatocellular and hepatobiliary toxicity indicated transient hepatotoxicity in TCDD-treated OVX rats receiving 17 ß-estradiol. Histopathological alterations indicated hepatotoxicity induced by exposure to TCDD following either 20 or 30 weeks of exposure. No excess hepatotoxicity was associated with 17 ß-estradiol-supplementation in TCDD-exposed OVX female Sprague-Dawley rats. Serum 17 ß-estradiol concentrations were not constant and resulted in supra-physiological levels that decreased over time, resulting in target physiological serum 17 ß-estradiol concentrations following several weeks of release. Treatment with 17 ß-estradiol resulted in uterine weights and total body weights comparable to sham-operated female rats. These data confirm the efficacy of supplemental subcutaneous 17 ß-estradiol pellets on the induction of estrogenic responses in TCDD-treated rats and indicate no increased hepatotoxicity associated with 17 ß-estradiol exposure in TCDD-treated rats.

Key Words: 2,3,7,8-tetrachlorodibenzo-p-dioxin; 17 ß-estradiol; hepatocarcinogenesis; clinical chemistry; subcutaneous pellets.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
M. E. Wyde, T. Cambre, M. Lebetkin, S. R. Eldridge, and N. J. Walker
Promotion of Altered Hepatic Foci by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and 17{beta}-estradiol in Male Sprague-Dawley Rats
Toxicol. Sci., August 1, 2002; 68(2): 295 - 303.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.